These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 16565509)

  • 21. The MAPK(ERK-1,2) pathway integrates distinct and antagonistic signals from TGFalpha and FGF7 in morphogenesis of mouse mammary epithelium.
    Fata JE; Mori H; Ewald AJ; Zhang H; Yao E; Werb Z; Bissell MJ
    Dev Biol; 2007 Jun; 306(1):193-207. PubMed ID: 17448457
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of estrogen signaling pathways collaborates with loss of Brca1 to promote development of ERalpha-negative and ERalpha-positive mammary preneoplasia and cancer.
    Jones LP; Tilli MT; Assefnia S; Torre K; Halama ED; Parrish A; Rosen EM; Furth PA
    Oncogene; 2008 Jan; 27(6):794-802. PubMed ID: 17653086
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transforming growth factor-alpha promotes mammary tumorigenesis through selective survival and growth of secretory epithelial cells.
    Smith GH; Sharp R; Kordon EC; Jhappan C; Merlino G
    Am J Pathol; 1995 Oct; 147(4):1081-96. PubMed ID: 7573353
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estrogen receptor beta growth-inhibitory effects are repressed through activation of MAPK and PI3K signalling in mammary epithelial and breast cancer cells.
    Cotrim CZ; Fabris V; Doria ML; Lindberg K; Gustafsson JÅ; Amado F; Lanari C; Helguero LA
    Oncogene; 2013 May; 32(19):2390-402. PubMed ID: 22751110
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Accelerated mammary maturation and differentiation, and delayed MMTVneu-induced tumorigenesis of K303R mutant ERalpha transgenic mice.
    Herynk MH; Lewis MT; Hopp TA; Medina D; Corona-Rodriguez A; Cui Y; Beyer AR; Fuqua SA
    Oncogene; 2009 Sep; 28(36):3177-87. PubMed ID: 19561644
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polyclonal development of mouse mammary preneoplastic nodules.
    Kisseberth WC; Sandgren EP
    Cancer Res; 2004 Feb; 64(3):857-63. PubMed ID: 14871812
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular characterizations of Nop16 in murine mammary tumors with varying levels of c-Myc.
    Kundel DW; Stromquist E; Greene AL; Zhdankin O; Regal RR; Rose-Hellekant TA
    Transgenic Res; 2012 Apr; 21(2):393-406. PubMed ID: 21863248
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acceleration of mammary neoplasia in transforming growth factor alpha transgenic mice by 7,12-dimethylbenzanthracene.
    Coffey RJ; Meise KS; Matsui Y; Hogan BL; Dempsey PJ; Halter SA
    Cancer Res; 1994 Apr; 54(7):1678-83. PubMed ID: 8137281
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overexpression of the colony-stimulating factor (CSF-1) and/or its receptor c-fms in mammary glands of transgenic mice results in hyperplasia and tumor formation.
    Kirma N; Luthra R; Jones J; Liu YG; Nair HB; Mandava U; Tekmal RR
    Cancer Res; 2004 Jun; 64(12):4162-70. PubMed ID: 15205327
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cause of failure of lactation in mouse mammary tumor virus/human transforming growth factor alpha transgenic mice.
    Sakai S; Mizuno M; Harigaya T; Yamamoto K; Mori T; Coffey RJ; Nagasawa H
    Proc Soc Exp Biol Med; 1994 Mar; 205(3):236-42. PubMed ID: 8171044
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overexpression of aromatase leads to hyperplasia and changes in the expression of genes involved in apoptosis, cell cycle, growth, and tumor suppressor functions in the mammary glands of transgenic mice.
    Kirma N; Gill K; Mandava U; Tekmal RR
    Cancer Res; 2001 Mar; 61(5):1910-8. PubMed ID: 11280746
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overexpression of human Cripto-1 in transgenic mice delays mammary gland development and differentiation and induces mammary tumorigenesis.
    Sun Y; Strizzi L; Raafat A; Hirota M; Bianco C; Feigenbaum L; Kenney N; Wechselberger C; Callahan R; Salomon DS
    Am J Pathol; 2005 Aug; 167(2):585-97. PubMed ID: 16049342
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elevated collagen-I augments tumor progressive signals, intravasation and metastasis of prolactin-induced estrogen receptor alpha positive mammary tumor cells.
    Barcus CE; O'Leary KA; Brockman JL; Rugowski DE; Liu Y; Garcia N; Yu M; Keely PJ; Eliceiri KW; Schuler LA
    Breast Cancer Res; 2017 Jan; 19(1):9. PubMed ID: 28103936
    [TBL] [Abstract][Full Text] [Related]  

  • 34. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.
    Cabodi S; Tinnirello A; Di Stefano P; Bisarò B; Ambrosino E; Castellano I; Sapino A; Arisio R; Cavallo F; Forni G; Glukhova M; Silengo L; Altruda F; Turco E; Tarone G; Defilippi P
    Cancer Res; 2006 May; 66(9):4672-80. PubMed ID: 16651418
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High incidence of mammary intraepithelial neoplasia development in Men1-disrupted murine mammary glands.
    Seigne C; Auret M; Treilleux I; Bonnavion R; Assade F; Carreira C; Goddard-Léon S; Lavergne E; Chabaud S; Garcia A; Mazoyer S; Lu J; Bachelot T; Frappart L; Zhang CX
    J Pathol; 2013 Mar; 229(4):546-58. PubMed ID: 23180448
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synergistic interaction of transforming growth factor alpha and c-myc in mouse mammary and salivary gland tumorigenesis.
    Amundadottir LT; Johnson MD; Merlino G; Smith GH; Dickson RB
    Cell Growth Differ; 1995 Jun; 6(6):737-48. PubMed ID: 7669729
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stimulation of insulin-like growth factor (IGF) binding protein-3 synthesis by IGF-I and transforming growth factor-alpha is mediated by both phosphatidylinositol-3 kinase and mitogen-activated protein kinase pathways in mammary epithelial cells.
    Sivaprasad U; Fleming J; Verma PS; Hogan KA; Desury G; Cohick WS
    Endocrinology; 2004 Sep; 145(9):4213-21. PubMed ID: 15192040
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of mammary hyperplasia and neoplasia in MMTV-TGF alpha transgenic mice.
    Matsui Y; Halter SA; Holt JT; Hogan BL; Coffey RJ
    Cell; 1990 Jun; 61(6):1147-55. PubMed ID: 2161707
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estrogen receptor alpha is required for mammary development and the induction of mammary hyperplasia and epigenetic alterations in the aromatase transgenic mice.
    Tekmal RR; Liu YG; Nair HB; Jones J; Perla RP; Lubahn DB; Korach KS; Kirma N
    J Steroid Biochem Mol Biol; 2005 May; 95(1-5):9-15. PubMed ID: 15955696
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vivo evidence for epidermal growth factor receptor (EGFR)-mediated release of prolactin from the pituitary gland.
    Dahlhoff M; Blutke A; Wanke R; Wolf E; Schneider MR
    J Biol Chem; 2011 Nov; 286(45):39297-306. PubMed ID: 21914800
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.